News Mounjaro Becomes First-in-Class Treatment for Type 2 Diabetes May 13, 2022 Read More » Esbriet Generic Available to Treat Rare Lung Disease May 12, 2022 Read More » FDA Approves New Oral Medication for ALS May 12, 2022 Read More » Olumiant Gains FDA Approval to Treat COVID-19 in Adults May 11, 2022 Read More » FDA Restricts Authorization of Janssen’s COVID-19 Vaccine May 5, 2022 Read More » Enhertu Obtains Regular FDA Approval After Accelerated Approval May 4, 2022 Read More » Voquezna Approved to Treat Common Cause of Stomach Ulcers May 4, 2022 Read More » FDA Approves First Nonstimulant ADHD Drug for Adults in 20 Years May 2, 2022 Read More » Cuvrior Approved for Life-Threatening Genetic Disorder May 2, 2022 Read More » Page1 … Page33 Page34 Page35 Page36 Page37 … Page43 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required) Email(Required) Comment(Required) Company Name(Required) CAPTCHA